
ALT This collaborative project, undertaken by the BSE NSTEP group, provides an updated assessment on stress echo delivery and staffing across a group of NHS hospitals. The study which recruited 8500 individuals, was designed to investigate the workforce delivering stress echo services and patient demographics. In doing so we compared study details of both physiologist/scientist and nurse led stress echo to doctor led stress echo across a range of different parameters. The results highlight the impact that physiologist/scientist led services are having with over 40% of all studies being performed in either a physiologist/scientist or nurse-led service, across a range of different stress modalities. Interestingly, reporting of stress echo results remains predominately doctor-led though later studies indicate an increase in independent physiologist/scientist reporting also. The study data highlights a modern, multi-professional workforce James Willis, Royal United Hospitals Bath, author"

ALT "Our paper describes the development of a pioneering service in which clinical scientists in cardiology lead routine follow-up care for adults with congenital heart disease (ACHD). It outlines the essential steps required to establish a clinical service, including pathway design, protocols, training, governance, the evaluation of safety, outcomes and the patient experience. Not only is it the first publication to describe such a model in detail in the UK, but it also provides a replicable framework that aligns with the NHS ambition to advance clinical practice among clinical scientists within a clearly defined scope of practice. By demonstrating that scientist-led clinics are effective, safe and cost-efficient, we show how this model can increase capacity, reduce waiting times and release ACHD consultant cardiologists' time to see more complex cases. We believe this work developed by our team at Guy’s and St Thomas’ represents an important milestone for clinical scientists"

ALT "Aortic stenosis (AS) is a common valvular heart condition with treatment options being limited to aortic valve replacement. A recently developed staging system, called cardiac damage, has been shown to help predict outcomes. This systematic review of 18 studies (21,876 patients, mean age 79, 52.7% males) assessed cardiac damage in patients with AS. Its findings showed that cardiac damage was highly prevalent: 76% in symptomatic severe AS and 88% in asymptomatic moderate/severe AS and mortality rates rose with advancing cardiac damage stage, especially in cardiac damage stage 3 and 4. This review highlights that cardiac damage staging may have prognostic value for the timing of aortic valve replacement."

ALT Authors: Faraz H. Khan, Debbie Zhao, Jong-Won Ha, Sherif F. Nagueh, Jens-Uwe Voigt, Allan L. Klein, Einar Gude, Kaspar Broch, Nicholas Chan, Gina M. Quill, Robert N. Doughty, Alistair Young, Ji-Won Seo, Eusebio García-Izquierdo, Vanessa Moñivas-Palomero, Susana Mingo-Santos, Tom Kai Ming Wang, Stephanie Bezy, Nobuyuki Ohte, Helge Skulstad, Carmen C. Beladan, Bogdan A. Popescu, Shohei Kikuchi, Vasileios Panis, Erwan Donal, Espen W. Remme, Martyn P. Nash and Otto A. Smiseth















